These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27712701)

  • 1. A Framework for Incorporating Patient Preferences Regarding Benefits and Risks into Regulatory Assessment of Medical Technologies.
    Ho M; Saha A; McCleary KK; Levitan B; Christopher S; Zandlo K; Braithwaite RS; Hauber AB;
    Value Health; 2016; 19(6):746-750. PubMed ID: 27712701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ISPOR, the FDA, and the Evolving Regulatory Science of Medical Device Products.
    O'Neill T; Miksad R; Miller D; Maloney L; John A; Hiller C; Hornberger J
    Value Health; 2019 Jul; 22(7):754-761. PubMed ID: 31277820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating patient-preference evidence into regulatory decision making.
    Ho MP; Gonzalez JM; Lerner HP; Neuland CY; Whang JM; McMurry-Heath M; Hauber AB; Irony T
    Surg Endosc; 2015 Oct; 29(10):2984-93. PubMed ID: 25552232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Preferences in Regulatory Benefit-Risk Assessments: A US Perspective.
    Johnson FR; Zhou M
    Value Health; 2016; 19(6):741-745. PubMed ID: 27712700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The new collaborative path in medical device development: the medical device innovation consortium.
    Kampfrath T; Cotten SW
    Clin Biochem; 2013 Oct; 46(15):1320-2. PubMed ID: 23578741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for Duchenne muscular dystrophy.
    Peay HL; Hollin I; Fischer R; Bridges JF
    Clin Ther; 2014 May; 36(5):624-37. PubMed ID: 24852596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring Patient Preferences at the FDA Center for Devices and Radiological Health: Reflections and Projections.
    Webber CM; Chen AL; Gebben DJ; Saha A; Tarver ME
    Value Health; 2021 Jul; 24(7):1024-1029. PubMed ID: 34243826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing a Patient-Centered Benefit-Risk Survey: A Community-Engaged Process.
    Hollin IL; Caroline Young ; Hanson C; Bridges JFP; Peay H
    Value Health; 2016; 19(6):751-757. PubMed ID: 27712702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating the Voice of the Patient Into the Medical Device Regulatory Process Using Patient Preference Information.
    Benz HL; Saha A; Tarver ME
    Value Health; 2020 Mar; 23(3):294-297. PubMed ID: 32197723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying benefit-risk preferences for medical interventions: an overview of a growing empirical literature.
    Brett Hauber A; Fairchild AO; Reed Johnson F
    Appl Health Econ Health Policy; 2013 Aug; 11(4):319-29. PubMed ID: 23637054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Ball is in Your Court: Agenda for Research to Advance the Science of Patient Preferences in the Regulatory Review of Medical Devices in the United States.
    Levitan B; Hauber AB; Damiano MG; Jaffe R; Christopher S
    Patient; 2017 Oct; 10(5):531-536. PubMed ID: 28831745
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuroprosthetics and the science of patient input.
    Benz HL; Civillico EF
    Exp Neurol; 2017 Jan; 287(Pt 4):486-491. PubMed ID: 27456271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The "déjà vu effect:" evaluation of United States medical device legislation, regulation, and the Food and Drug Administration's contentious 510(k) program.
    Bauman J
    Food Drug Law J; 2012; 67(3):337-61, i. PubMed ID: 24624654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective Partnering in Conducting Benefit-Risk Patient Preference Studies: Perspectives From a Patient Advocacy Organization, a Pharmaceutical Company, and Academic Stated-Preference Researchers.
    Wolka AM; Fairchild AO; Reed SD; Anglin G; Johnson FR; Siegel M; Noel R
    Ther Innov Regul Sci; 2018 Jul; 52(4):507-513. PubMed ID: 29714550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Center for Devices and Radiological health: an update.
    Donawa M
    Med Device Technol; 2001 Dec; 12(10):24, 26-7. PubMed ID: 15966141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA use of international standards in the premarket review process.
    Rechen E; Barth DJ; Marlowe D; Kroger L
    Biomed Instrum Technol; 1998; 32(5):518-26. PubMed ID: 9800008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technology assessment of medical devices at the Center for Devices and Radiological Health.
    Kessler L; Richter K
    Am J Manag Care; 1998 Sep; 4 Spec No():SP129-35. PubMed ID: 10185989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Human Genome Project in the United States: a perspective on the commercial, ethical, legislative and health care issues.
    Mackler BF; Barach M
    J Int Bioethique; 1991; 2(3):149-57. PubMed ID: 11654898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report.
    Coons SJ; Gwaltney CJ; Hays RD; Lundy JJ; Sloan JA; Revicki DA; Lenderking WR; Cella D; Basch E;
    Value Health; 2009 Jun; 12(4):419-29. PubMed ID: 19900250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-Focused Benefit-Risk Analysis to Inform Regulatory Decisions: The European Union Perspective.
    Mühlbacher AC; Juhnke C; Beyer AR; Garner S
    Value Health; 2016; 19(6):734-740. PubMed ID: 27712699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.